|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-6-20
|
|
pubmed:abstractText |
The aim of this study was to assess changes in the size and cholesterol content of low-density lipoproteins (LDL) and changes in lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in HIV-infected patients switching to tenofovir + emtricitabine (TDF+FTC) or abacavir + lamivudine (ABC+3TC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adenine,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine,
http://linkedlifedata.com/resource/pubmed/chemical/Dideoxynucleosides,
http://linkedlifedata.com/resource/pubmed/chemical/Lamivudine,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Phospholipases A2,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphonic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/abacavir,
http://linkedlifedata.com/resource/pubmed/chemical/emtricitabine,
http://linkedlifedata.com/resource/pubmed/chemical/tenofovir
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
2040-2058
|
|
pubmed:author |
pubmed-author:BarragánPatriciaP,
pubmed-author:Bicombo-met Substudy Team,
pubmed-author:BonetRosaR,
pubmed-author:CurranAdrianA,
pubmed-author:GatellJosep MariaJM,
pubmed-author:KnobelHernandoH,
pubmed-author:LoncáMontserratM,
pubmed-author:MartínezEstebanE,
pubmed-author:NegredoEugeniaE,
pubmed-author:Ordoñez-LlanosJordiJ,
pubmed-author:PodzamczerDanielD,
pubmed-author:RiberaEstebanE,
pubmed-author:SaumoyMariaM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
459-68
|
|
pubmed:meshHeading |
pubmed-meshheading:21685533-Adenine,
pubmed-meshheading:21685533-Adult,
pubmed-meshheading:21685533-Anti-HIV Agents,
pubmed-meshheading:21685533-Cardiovascular Diseases,
pubmed-meshheading:21685533-Cholesterol, LDL,
pubmed-meshheading:21685533-Clinical Protocols,
pubmed-meshheading:21685533-Deoxycytidine,
pubmed-meshheading:21685533-Dideoxynucleosides,
pubmed-meshheading:21685533-Drug Therapy, Combination,
pubmed-meshheading:21685533-Female,
pubmed-meshheading:21685533-HIV Infections,
pubmed-meshheading:21685533-HIV-1,
pubmed-meshheading:21685533-Humans,
pubmed-meshheading:21685533-Lamivudine,
pubmed-meshheading:21685533-Lipoproteins,
pubmed-meshheading:21685533-Lipoproteins, LDL,
pubmed-meshheading:21685533-Male,
pubmed-meshheading:21685533-Middle Aged,
pubmed-meshheading:21685533-Phospholipases A2,
pubmed-meshheading:21685533-Phosphonic Acids,
pubmed-meshheading:21685533-Reverse Transcriptase Inhibitors
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Low-density lipoprotein size and lipoprotein-associated phospholipase A2 in HIV-infected patients switching to abacavir or tenofovir.
|
|
pubmed:affiliation |
Infectious Disease Service, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
